CS logo
small CS logo
Boston University School Of Medicine

Boston, Massachusetts, United States
Medical school in Boston, Massachusetts
72 E Concord St, Boston, MA 02118

About Boston University School Of Medicine


The Boston University School of Medicine is one of the graduate schools of Boston University. Founded in 1848, the medical school was the first institution in the world to formally educate female physicians. Originally known as the New England Female Medical College, it was subsequently renamed BUSM in 1873.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boston University
20
Actelion
10
National Institute of Allergy and Infectious Diseases (NIAID)
9
University of Pennsylvania
8
National Institute on Aging (NIA)
4
Ionis Pharmaceuticals, Inc.
3
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
3
National Cancer Institute (NCI)
3
Prothena Biosciences Ltd.
3
Reata Pharmaceuticals, Inc.
3
Aires Pharmaceuticals, Inc.
2
Total Rows: 67

Clinical Trials at Boston University School Of Medicine


During the past decade, Boston University School Of Medicine conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 28 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4411111111222222335522442244334455222222Started TrialsCompleted Trails201520162017201820192020202120222023051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prevention of Arthritis-Related Work Disability
1997-09-01
2001-08-01
Completed
242
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
1996-01-01
2007-09-01
Completed
Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
15
Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers
1997-09-01
2005-02-01
Completed
23
Oral Type I Collagen for Relieving Scleroderma
2000-04-01
Completed
168
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia
1999-03-01
Completed
15
COMBINE (Acamprosate/Naltrexone)
1997-08-01
2006-05-01
Completed
1,375
Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
2001-01-01
Completed
2,625

Rows per page:

1–100 of 139

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Boston University School Of Medicine" #1 sponsor was "Boston University" with 20 trials, followed by "Actelion" with 10 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials sponsored, "University of Pennsylvania" with 8 trials sponsored and "National Institute on Aging (NIA)" with 8 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 67 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Boston University School Of Medicine" #1 collaborator was "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 12 trials as a collaborator, "National Institute on Aging (NIA)" with 8 trials as a collaborator, "Office of Rare Diseases (ORD)" with 8 trials as a collaborator, "Rare Diseases Clinical Research Network" with 6 trials as a collaborator and "Inner-City Asthma Consortium" with 5 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 86 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Boston University School Of Medicine


According to Clinical.Site data, the most researched conditions in "Boston University School Of Medicine" are "Pulmonary Hypertension" (11 trials), "Pulmonary Arterial Hypertension" (10 trials), "Alzheimer's Disease" (9 trials), "Asthma" (9 trials) and "Alzheimer Disease" (6 trials). Many other conditions were trialed in "Boston University School Of Medicine" in a lesser frequency.

Clinical Trials Intervention Types at Boston University School Of Medicine


Most popular intervention types in "Boston University School Of Medicine" are "Drug" (89 trials), "Other" (15 trials), "Behavioral" (10 trials), "Biological" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (17 trials), "Laboratory Biomarker Analysis" (5 trials), "placebo" (4 trials), "Bosentan" (3 trials) and "Eplontersen" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Boston University School Of Medicine


The vast majority of trials in "Boston University School Of Medicine" are 133 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Clinical Trials Status at Boston University School Of Medicine


Currently, there are 23 active trials in "Boston University School Of Medicine". 1 are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 89 completed trials in Boston University School Of Medicine, undefined suspended trials, and 20 terminated clinical trials to date.
Out of the total trials that were conducted in Boston University School Of Medicine, 10 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 19 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status